These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8228692

  • 1. Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
    Chayakul P, Krisanapan S, Kalnauwakul S.
    J Med Assoc Thai; 1993 Jan; 76(1):35-40. PubMed ID: 8228692
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
    Valtonen V, Karppinen L, Kariniemi AL.
    Scand J Infect Dis Suppl; 1989 Mar; 60():79-83. PubMed ID: 2547245
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F, Torroba L, Buzón L, Martínez-Beltrán J, Loza E, Baquero F.
    Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of ciprofloxacin for the treatment of severe bacterial infections].
    López JC, offcenado E, Rodríguez-Créixems M, Romero J, García de la Torre M, Bouza E.
    Enferm Infecc Microbiol Clin; 1989 Jan; 7(1):23-8. PubMed ID: 2490638
    [Abstract] [Full Text] [Related]

  • 16. Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review.
    Norrby SR.
    Scand J Infect Dis Suppl; 1989 Jan; 60():74-8. PubMed ID: 2667110
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [Abstract] [Full Text] [Related]

  • 18. Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
    Giamarellou H, Daphnis E, Dendrinos C, Daikos GK.
    Drugs Exp Clin Res; 1985 Sep; 11(5):351-6. PubMed ID: 2941264
    [Abstract] [Full Text] [Related]

  • 19. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
    Gilbert DN, Tice AD, Marsh PK, Craven PC, Preheim LC.
    Am J Med; 1987 Apr 27; 82(4A):254-8. PubMed ID: 3555044
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.